-
341por Kaminskyy, Danylo, Khyluk, Dmytro, Vasylenko, Olexandr, Zaprutko, Lucjusz, Lesyk, Roman“…The structure of the compounds was determined by (1)H and (13)C NMR and their in vitro anticancer activity was tested in the National Cancer Institute. Among the tested compounds, (5′Z)-5′-(benzylidene)-3′-(4-chlorophenyl)spiro[3H-indole-3,2′-thia-zolidine]-2,4′(1H)-dione (IIa) and (5′Z)-3′-(4-chlorophenyl)-5′-[4-(1-methylethyl)-benzylidene]spiro[3H-indole-3,2′-thiazolidine]-2,4′(1H)-dione (IIb) were superior to other related compounds.…”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
342por Farrell, Margaret M., La Porta, Madeline, Gallagher, Alissa, Vinson, Cynthia, Bernal, Sarah Bruce“…In 2011, the National Cancer Institute (NCI) launched an online community of practice, Research to Reality (R2R). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343por Friedman, Daniela B., Brandt, Heather M., Freedman, Darcy A., Adams, Swann Arp, Young, Vicki M., Ureda, John R., McCracken, James Lyndon, Hébert, James R.“…The South Carolina Cancer Prevention and Control Research Network (SC-CPCRN) is 1 of 10 networks funded by the Centers for Disease Control and Prevention and the National Cancer Institute (NCI) that works to reduce cancer-related health disparities. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
344por Sahoo, Satya S, Tao, Shiqiang, Parchman, Andrew, Luo, Zhihui, Cui, Licong, Mergler, Patrick, Lanese, Robert, Barnholtz-Sloan, Jill S, Meropol, Neal J, Zhang, Guo-Qiang“…We report the results from deployment of Trial Prospector at the National Cancer Institute (NCI)-designated Case Comprehensive Cancer Center (Case CCC) with 1,367 clinical trial eligibility evaluations performed with 100% accuracy.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
345por ÑAMENDYS-SILVA, SILVIO A., CORREA-GARCÍA, PAULINA, GARCÍA-GUILLÉN, FRANCISCO J., LÓPEZ-BASAVE, HORACIO N., MONTALVO-ESQUIVEL, GONZALO, TEXCOCANO-BECERRA, JULIA, HERRERA-GÓMEZ, ÁNGEL, MENESES-GARCÍA, ABELARDO“…The present study included 25 critically ill cancer patients admitted to the ICU of the National Cancer Institute (Mexico City, Mexico) between January 2007 and February 2013. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
346“…A CA definition is required for cancer centers applying for National Cancer Institute (NCI)-designated cancer center status. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
347“…The in vitro antitumor activity of some compounds was evaluated in the US National Cancer Institute (NCI) against the NCI-60 cell line panel. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
348por Usher-Smith, Juliet, Emery, Jon, Hamilton, Willie, Griffin, Simon J, Walter, Fiona M“…These potential uses have been recognised by the National Cancer Institute as an ‘area of extraordinary opportunity' and an increasing number of risk prediction models continue to be developed. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
349por Mendoza-Valdés, Arturo“…In that time, I was the head of the Department of Urology of the Mexican National Cancer Institute and our Director, Dr. Jaime de la Garza, invited him for a meeting. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
350por Gulley, James L., Berzofsky, Jay A., Butler, Marcus O., Cesano, Alessandra, Fox, Bernard A., Gnjatic, Sacha, Janetzki, Sylvia, Kalavar, Shyam, Karanikas, Vaios, Khleif, Samir N., Kirsch, Ilan, Lee, Peter P., Maccalli, Cristina, Maecker, Holden, Schlom, Jeffrey, Seliger, Barbara, Siebert, Janet, Stroncek, David F., Thurin, Magdalena, Yuan, Jianda, Butterfield, Lisa H.“…The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
351por Baker, Darren J., Alimirah, Fatouma, van Deursen, Jan M., Campisi, Judith, Hildesheim, Jeffrey“…On June 23(rd) and 24(th), 2016, the Division of Cancer Biology of the National Cancer Institute sponsored a workshop to discuss the complex role of cellular senescence in tumorigenesis with the goal to define the major challenges and opportunities within this important field of cancer research. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
352por Farahani, Keyvan, Kalpathy-Cramer, Jayashree, Chenevert, Thomas L., Rubin, Daniel L., Sunderland, John J., Nordstrom, Robert J., Buatti, John, Hylton, Nola“…The Quantitative Imaging Network (QIN) of the National Cancer Institute (NCI) conducts research in development and validation of imaging tools and methods for predicting and evaluating clinical response to cancer therapy. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
353por MacKay, Helen J., Levine, Douglas A., Bae-Jump, Victoria L., Bell, Daphne W., McAlpine, Jessica N., Santin, Alessandro, Fleming, Gini F., Mutch, David G., Nephew, Kenneth P., Wentzensen, Nicolas, Goodfellow, Paul J., Dorigo, Oliver, Nijman, Hans W., Broaddus, Russell, Kohn, Elise C.“…There have been no new drugs approved for the treatment of endometrial cancer in decades. The National Cancer Institute, Gynecologic Cancer Steering Committee identified the integration of molecular and/or histologic stratification into endometrial cancer management as a top strategic priority. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
354por Graziano, Francesca, Bavisotto, C. Caruso, Gammazza, A. Marino, Rappa, Francesca, de Macario, Everly Conway, Macario, Albert J. L., Cappello, Francesco, Campanella, Claudia, Maugeri, Rosario, Iacopino, Domenico Gerardo“…The European Organization for Research and Treatment of Cancer/National Cancer Institute of Canada Phase III trial has validated as a current regimen for high-grade gliomas (HGG) a maximal safe surgical resection followed by radiotherapy with concurrent temozolamide. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
355“…The study used a descriptive cross-sectional design using the 2017 Health Information National Trends Survey (HINTS) data collected by the National Cancer Institute. Adherence was defined based on the guidelines from the American Cancer Society and the composite measure of shared decision-making was constructed using three items in the data. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
356“…About one-third of adult patients outlive their leukemia, with the remainder unable to attain complete remission status following the first phase of treatment due to refractory bone marrow or blood residual microscopic disease. The National Cancer Institute (NCI) Cancer Therapy Evaluation Program conducted 49 phase 1-1b trials in adult patients with leukemia between 1986 and 2017 in an effort to discover tolerated and effective therapeutic drug combinations intended to improve remission and mortality rates. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
357“…In this article, we conduct survival analysis on patients with brain tumors using the SEER (Surveillance, Epidemiology, and End Results) database from the NCI (National Cancer Institute). It has been recognized that cancer survival models have spatial and temporal variations which are caused by multiple factors, but such variations are usually not “abrupt” (that is, they should be smooth). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
358“…The present work focuses on facilitating the identification of new PKIs with antitumoral potential through the use of data-mining and basic statistics. The National Cancer Institute (NCI) granted access to the results of numerous previously tested compounds on 60 tumoral cell lines (NCI-60 panel). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
359por Martins, João Pedro, das Neves, José, de la Fuente, María, Celia, Christian, Florindo, Helena, Günday-Türeli, Nazende, Popat, Amirali, Santos, José Luis, Sousa, Flávia, Schmid, Ruth, Wolfram, Joy, Sarmento, Bruno, Santos, Hélder A.“…This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
360por Kuruppu, Daya Chandrani, Wijeyaratne, Chandrika Neelakanthi, Gunawardane, Nalika, Amarasinghe, Indrani“…OBJECTIVE: This study assessed the information needs of breast cancer (BC) patients who presented themselves to the outpatient clinics or wards of the National Cancer Institute, Maharagama, Sri Lanka. METHODS: Information needs were measured using the validated questionnaire in the vernacular (Sri Lankan Information Needs Assessment Questionnaire – BC). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto